High Tower Advisors, LLC Crispr Therapeutics Ag Transaction History

High Tower Advisors, LLC

  • $76.8 Billion
  • Q2 2025

A detailed history of High Tower Advisors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, High Tower Advisors, LLC holds 49,196 shares of CRSP stock, worth $2.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,196
Previous 33,033 48.93%
Holding current value
$2.78 Million
Previous $1.12 Million 112.81%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$31.27 - $48.64 $505,417 - $786,168
16,163 Added 48.93%
49,196 $2.39 Million
Q1 2025

May 12, 2025
BUY
$34.03 - $53.02 $45,089 - $70,251
1,325 Added 4.18%
33,033 $1.12 Million
Q4 2024

Feb 07, 2025
SELL
$38.65 - $55.15 $255,399 - $364,431
-6,608 Reduced 17.25%
31,708 $1.25 Million
Q3 2024

Nov 14, 2024
SELL
$44.62 - $62.75 $60,192 - $84,649
-1,349 Reduced 3.4%
38,316 $1.8 Million
Q2 2024

Aug 13, 2024
SELL
$51.17 - $68.18 $148,802 - $198,267
-2,908 Reduced 6.83%
39,665 $2.14 Million
Q1 2024

May 06, 2024
BUY
$60.67 - $89.12 $305,958 - $449,432
5,043 Added 13.44%
42,573 $2.9 Million
Q4 2023

Feb 12, 2024
SELL
$38.62 - $72.18 $95,198 - $177,923
-2,465 Reduced 6.16%
37,530 $2.35 Million
Q3 2023

Nov 08, 2023
SELL
$45.39 - $59.0 $1,634 - $2,124
-36 Reduced 0.09%
39,995 $1.82 Million
Q2 2023

Aug 14, 2023
SELL
$43.47 - $67.77 $9,911 - $15,451
-228 Reduced 0.57%
40,031 $2.25 Million
Q1 2023

May 11, 2023
BUY
$41.0 - $56.12 $399,627 - $547,001
9,747 Added 31.94%
40,259 $1.82 Million
Q4 2022

Feb 08, 2023
SELL
$39.19 - $65.67 $191,952 - $321,651
-4,898 Reduced 13.83%
30,512 $1.24 Million
Q3 2022

Nov 09, 2022
BUY
$61.1 - $83.78 $86,823 - $119,051
1,421 Added 4.18%
35,410 $2.32 Million
Q2 2022

Aug 10, 2022
SELL
$43.23 - $73.83 $687,097 - $1.17 Million
-15,894 Reduced 31.86%
33,989 $2.06 Million
Q1 2022

May 12, 2022
BUY
$53.19 - $79.24 $877,315 - $1.31 Million
16,494 Added 49.4%
49,883 $3.13 Million
Q4 2021

Feb 10, 2022
SELL
$70.09 - $111.29 $684,779 - $1.09 Million
-9,770 Reduced 22.64%
33,389 $2.54 Million
Q3 2021

Nov 12, 2021
BUY
$110.2 - $156.64 $331,261 - $470,859
3,006 Added 7.49%
43,159 $4.83 Million
Q2 2021

Aug 06, 2021
BUY
$100.84 - $161.89 $1.08 Million - $1.73 Million
10,668 Added 36.18%
40,153 $6.49 Million
Q1 2021

May 10, 2021
BUY
$110.72 - $210.04 $333,710 - $633,060
3,014 Added 11.39%
29,485 $3.58 Million
Q4 2020

Feb 10, 2021
BUY
$79.67 - $173.23 $119,265 - $259,325
1,497 Added 5.99%
26,471 $4.05 Million
Q3 2020

Nov 13, 2020
SELL
$78.5 - $100.64 $30,222 - $38,746
-385 Reduced 1.52%
24,974 $2.09 Million
Q2 2020

Aug 10, 2020
BUY
$38.5 - $76.05 $185,146 - $365,724
4,809 Added 23.4%
25,359 $1.86 Million
Q1 2020

May 21, 2020
BUY
$33.68 - $62.53 $62,308 - $115,680
1,850 Added 9.89%
20,550 $873,000
Q4 2019

Feb 14, 2020
BUY
$36.68 - $73.13 $39,431 - $78,614
1,075 Added 6.1%
18,700 $1.13 Million
Q3 2019

Nov 12, 2019
SELL
$40.99 - $52.56 $206,712 - $265,060
-5,043 Reduced 22.25%
17,625 $722,000
Q2 2019

Aug 13, 2019
BUY
$35.45 - $48.2 $89,440 - $121,608
2,523 Added 12.52%
22,668 $1.07 Million
Q1 2019

May 15, 2019
BUY
$28.02 - $40.87 $96,753 - $141,124
3,453 Added 20.69%
20,145 $721,000
Q4 2018

Feb 14, 2019
SELL
$22.73 - $42.34 $174,316 - $324,705
-7,669 Reduced 31.48%
16,692 $480,000
Q3 2018

Nov 09, 2018
BUY
$44.35 - $65.71 $218,202 - $323,293
4,920 Added 25.31%
24,361 $1.08 Million
Q2 2018

Aug 14, 2018
BUY
$42.62 - $73.59 $828,575 - $1.43 Million
19,441 New
19,441 $1.14 Million

Others Institutions Holding CRSP

# of Institutions
541
Shares Held
68.6M
Call Options Held
3.67M
Put Options Held
2.25M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.4B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email